BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25092874)

  • 1. RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.
    Verma R; Su S; McCrann DJ; Green JM; Leu K; Young PR; Schatz PJ; Silva JC; Stokes MP; Wojchowski DM
    J Exp Med; 2014 Aug; 211(9):1715-22. PubMed ID: 25092874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
    Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
    Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.
    Sathyanarayana P; Dev A; Pradeep A; Ufkin M; Licht JD; Wojchowski DM
    Blood; 2012 Jun; 119(23):5522-31. PubMed ID: 22508938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHEX in the mix of erythropoietin signaling molecules.
    Broxmeyer HE
    J Exp Med; 2014 Aug; 211(9):1704. PubMed ID: 25155719
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms.
    Miller CP; Heilman DW; Wojchowski DM
    Blood; 2002 Feb; 99(3):898-904. PubMed ID: 11806992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
    Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells.
    Li K; Menon MP; Karur VG; Hegde S; Wojchowski DM
    Blood; 2003 Nov; 102(9):3147-53. PubMed ID: 12869513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
    Fukumoto T; Kubota Y; Kitanaka A; Yamaoka G; Ohara-Waki F; Imataki O; Ohnishi H; Ishida T; Tanaka T
    Cell Signal; 2009 Dec; 21(12):1775-83. PubMed ID: 19665053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
    Menon MP; Karur V; Bogacheva O; Bogachev O; Cuetara B; Wojchowski DM
    J Clin Invest; 2006 Mar; 116(3):683-94. PubMed ID: 16511603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
    Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
    J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis.
    Held MA; Greenfest-Allen E; Jachimowicz E; Stoeckert CJ; Stokes MP; Wood AW; Wojchowski DM
    Exp Hematol; 2020 Apr; 84():29-44. PubMed ID: 32259549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors.
    van den Akker E; van Dijk T; Parren-van Amelsvoort M; Grossmann KS; Schaeper U; Toney-Earley K; Waltz SE; Löwenberg B; von Lindern M
    Blood; 2004 Jun; 103(12):4457-65. PubMed ID: 14982882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of SLAP in FLI-1-transformed erythroblasts interferes with EpoR signaling.
    Lebigot I; Gardellin P; Lefebvre L; Beug H; Ghysdael J; Quang CT
    Blood; 2003 Dec; 102(13):4555-62. PubMed ID: 12946994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core erythropoietin receptor signals for late erythroblast development.
    Menon MP; Fang J; Wojchowski DM
    Blood; 2006 Apr; 107(7):2662-72. PubMed ID: 16332976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.
    Slavova-Azmanova NS; Kucera N; Satiaputra J; Stone L; Magno A; Maxwell MJ; Quilici C; Erber W; Klinken SP; Hibbs ML; Ingley E
    Blood; 2013 Jul; 122(2):262-71. PubMed ID: 23692855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.
    Singh S; Dev A; Verma R; Pradeep A; Sathyanarayana P; Green JM; Narayanan A; Wojchowski DM
    PLoS One; 2012; 7(7):e38530. PubMed ID: 22808010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J; Yuan B; Hu W; Lodish H
    Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.